Comparative pharmacovigilance analyses of pimavanserin and mortality in Parkinson's disease

被引：0
|
作者：
Brown, Joshua [1 ]
Cicali, Brian [1 ]
Henriksen, Carl [1 ]
Malaty, Irene [2 ]
Okun, Michael [2 ]
Armstrong, Melissa [2 ]
机构：
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
2507
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [1] Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis
    Brown, Joshua D.
    Cicali, Brian
    Henriksen, Carl
    Malaty, Irene
    Okun, Michael S.
    Armstrong, Melissa J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (06): : 785 - 790
  • [2] Pimavanserin for the treatment of Parkinson's disease psychosis
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1969 - 1975
  • [3] Pimavanserin for the treatment of Parkinson's disease psychosis
    Chendo, Ines
    Ferreira, Joaquim J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (15) : 2115 - 2124
  • [4] Pimavanserin (Nuplazid) for Parkinson's Disease Psychosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1496): : 74 - 75
  • [5] Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine
    Moreno, Gabriel M.
    Gandhi, Rhea
    Lessig, Stephanie L.
    Wright, Brenton
    Litvan, Irene
    Nahab, Fatta B.
    NEUROLOGY, 2018, 91 (17) : 797 - 799
  • [6] Pimavanserin as treatment for Parkinson's disease psychosis
    Fox, Susan H.
    LANCET, 2014, 383 (9916): : 494 - 496
  • [7] MORTALITY RISK ASSOCIATED WITH PIMAVANSERIN FOR HALLUCINATIONS AND DELUSIONS ASSOCIATED WITH PARKINSON'S DISEASE PSYCHOSIS
    Isaacson, S.
    Pagan, F.
    Truong, D.
    Abler, V.
    Pahwa, R.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 49 - 49
  • [8] Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis
    Isaacson, Stuart H.
    Pahwa, Rajesh
    Pagan, Fernando
    Abler, Victor
    Truong, Daniel
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 10
  • [9] All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson's disease in Medicare
    Mosholder, A.
    Ma, Y.
    Akhtar, S.
    Podskalny, G.
    Wei, Y.
    Liao, J.
    Feng, Y.
    Lyu, H.
    Wernecke, M.
    Leishear, K.
    Nelson, L.
    MaCurdy, T.
    Kelman, J.
    Graham, D.
    MOVEMENT DISORDERS, 2020, 35 : S469 - S469
  • [10] Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis
    Sahli, Zeyad T.
    Tarazi, Frank I.
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (01) : 103 - 110
12345